Cargando…
Low dose intrapleural alteplase and pulmozyme (DNase) in two post-surgical patients with pleural sepsis
Alteplase and pulmozyme (DNase) administered intrapleurally have revolutionised the management of pleural infection in the last decade. However, the use of intrapleural fibrinolytic has not been well established in high risks patients. Here, we describe 2 patients with high risk of bleeding due to r...
Autores principales: | Faisal, M., Fazlin, M., Ng, B.H., Nuratiqah, N., Andrea, YL. Ban |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270608/ https://www.ncbi.nlm.nih.gov/pubmed/32518748 http://dx.doi.org/10.1016/j.rmcr.2020.101111 |
Ejemplares similares
-
Short-course modified regimen intrapleural alteplase and pulmozyme (DNase) in pleural infection
por: Faisal, M., et al.
Publicado: (2020) -
Modified regimen intrapleural alteplase with pulmozyme in pleural infection management: a tertiary teaching hospital experience
por: Cheong, Xiong Khee, et al.
Publicado: (2022) -
Correction: Modified regimen intrapleural alteplase with pulmozyme in pleural infection management: a tertiary teaching hospital experience
por: Cheong, Xiong Khee, et al.
Publicado: (2022) -
Retrospective review comparing intrapleural fibrinolytic therapy (alteplase) and surgical intervention in complex pleural effusion
por: Abdul Hamid, Mohamed Faisal, et al.
Publicado: (2022) -
Short‐course intrapleural alteplase and DNase in complex effusion with bleeding risk
por: Cheong, Xiong Khee, et al.
Publicado: (2020)